Navigation Links
Leading Egg Donor & Surrogacy Agency, ConceiveAbilities, Expands Its Surrogacy Program to Include a Support Group for Intended Parents
Date:6/13/2013

Chicago, IL (PRWEB) June 13, 2013

ConceiveAbilities is pleased to announce the expansion of its innovative surrogacy program to include a regular support group for intended parents. With the steep trajectory of surrogacy in the already overwhelming world of infertility, this unique kind of support is paramount and has been challenging to find until now.

The support group is an unparalleled opportunity to discuss the emotional aspects of surrogacy, including excitement, fear, loss of control, and sadness - all at the same time - with others who can relate. A myriad of unique factors, such a single parenting or parenting as a same-sex couple, often come into play and can benefit from this network of support.

“A defining feature of the ConceiveAbilities program is to offer innovative solutions to clients in a burgeoning field,” says President Nazca Fontes. “This new facet provides the setting for intended parents to explore their personal situations with others going through the same pioneering journey.”

The safe, comfortable environment is led by a professional with personal experience. Group leader and ConceiveAbilities’ Director of Surrogacy Deb Levy, MA, LPC, had her own children via the help of a gestational surrogate and is able to guide intended parents as they explore all aspects - emotional and logistical - about this path to parenthood.

For more information and to register for the support group please contact info(at)conceiveabilities(dot)com.

For more information about the gestational surrogacy program please visit ConceiveAbilities’ gestational surrogacy resource page.

For more information about family building options for LGBT clients please visit ConceiveAbilities’ LGBT egg donation and surrogacy page.

For more information about registering for free access to ConceiveAbilities’ online database of surrogates and egg donors, please visit the online registration page.

About ConceiveAbilities:

Since 1996, ConceiveAbilities has provided an unmatched level of service and support to intended parents, egg donors, and gestational surrogates; helping guide them through an often complicated process. They supply the tools and give the support necessary to simplify what can be a challenging road to parenthood.

The staff at ConceiveAbilities includes former egg donors, surrogate mothers, and intended parents. With this personal experience guiding their philosophy, the team is able to bring a very unique perspective to the table. They can provide all sides of the partnership with the best resources, support, and information to maximize the overall chance for success. As a result of this approach and experience, ConceiveAbilities has earned the respect of many of the nation’s leading fertility experts.

ConceiveAbilities is among a select few agencies that the most distinguished fertility resources in the U.S. refer patients to. They are the gold standard in service, recruitment, and matching in the fertility industry; with many fertility centers around the country choosing to work with them exclusively. Although headquartered in Chicago, Illinois, their surrogacy agency operates in cities all across the country, including Boston, Denver, and Houston.

Read the full story at http://www.prweb.com/releases/chicago/surrogacy/prweb10827060.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
2. Diabetes drug could treat leading cause of blindness
3. Pneumonia and preterm birth complications are the leading causes of childhood death
4. Leading health care quality expert is 2012 AcademyHealth Distinguished Investigator
5. Dr. Edmund Lipskis & Dr. Lynn Lipskis Will be Featured On New National Television Show Entitled: “Leading The Field” World Class Experts Share Their Tips & Advice
6. ACR: Medical imaging study in health affairs incomplete and potentially misleading
7. Poorly-performing hand implants unacceptable says leading medical journal
8. Leading cancer specialists from Europe and beyond recognized at ESMO 2012
9. WSU researchers discover mechanism leading from trichomoniasis to prostate cancer
10. Report: Cancer now leading cause of death in US hispanics
11. Leading stem cell scientists to focus on diabetes, eye diseases at Cedars-Sinai symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Huntington Beach, CA (PRWEB) , ... January 19, ... ... for Oral Health, is now offering treatments for patients with sleep apnea and ... far-reaching consequences for dental and physical health. Dr. Rassouli provides personalized care to ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... protection and financial planning services to communities throughout eastern Georgia, is embarking on ... heart disease. , Heart disease kills more Americans every year than anything else, ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages to prevent ... contest from Impact Teen Drivers and California Casualty. Entries from students aged 14-22 ... grants totaling $15,000 will be awarded for the best peer-to-peer messages sharing solutions ...
(Date:1/19/2017)... ... 19, 2017 , ... The 21st Century Cures Act’s Impact on Medical Devices:, ... 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , ... to thrive this year? , The passage of the act means devicemakers will be ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... American Osteopathic College of Proctology) announced today the opening of 3 medical ... ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids Center ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
(Date:1/19/2017)... 2017 Shire plc (LSE: SHP, ... Food and Drug Administration (FDA) has acknowledged receipt of ... (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts ... treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected ... 2017, the designated Prescription Drug User Fee Act (PDUFA) ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: